Oswald, Christine
Rappas, Mathieu
Kean, James
Doré, Andrew S.
Errey, James C.
Bennett, Kirstie
Deflorian, Francesca
Christopher, John A.
Jazayeri, Ali
Mason, Jonathan S.
Congreve, Miles
Cooke, Robert M.
Marshall, Fiona H.
Article History
Received: 3 August 2016
Accepted: 7 November 2016
First Online: 7 December 2016
Competing interests
: The authors are employees of Heptares Therapeutics and are shareholders of Sosei Group, the parent company of Heptares. Heptares is a drug discovery and development company working in the field of G-protein-coupled receptor structure-based drug design.